{"id":456,"date":"2014-05-16T18:43:34","date_gmt":"2014-05-16T18:43:34","guid":{"rendered":"http:\/\/discoveryrehab.com\/?page_id=456"},"modified":"2018-08-21T13:17:32","modified_gmt":"2018-08-21T13:17:32","slug":"20-things-to-know-about-eliquis-apixaban","status":"publish","type":"page","link":"https:\/\/discoveryrehab.com\/20-things-to-know-about-eliquis-apixaban\/","title":{"rendered":"20 Important Eliquis? Facts You Need to Know About (Apixaban)"},"content":{"rendered":"

\"eliquis<\/p>\n

1.) Eliquis (Apixaban)?is a relatively new medication and selective inhibitor.<\/b><\/h2>\n

It is used mainly to prevent harmful blood clots from forming in the blood vessels.<\/p>\n

Eliquis is mostly used to prevent blood clots for people who have had a total hip replacement or knee replacement surgery, for the prevention of venous thromboembolism (blood clots in the veins) and the prevention of stroke in atrial fibrillation.<\/p>\n

2.) The drug prevents clot formation by blocking an important pathway<\/b><\/h2>\n

Coagulation cascade is a series of reactions, by which, certain protein complex reacts with co-factors and become active components that then catalyze the next reaction in the series to make a bigger complex, ultimately resulting in cross-linked fibrin (blood clot).<\/p>\n

Eliquis prevents an important step in this series of reactions by selectively and reversibly blocking the active site of an enzyme (responsible for activation of Factor X to Factor Xa) without requiring a cofactor (e.g., antithrombin III) and breaks the chain to clot formation.?<\/span><\/p>\n

(<\/span>Activation of Factor X to Factor Xa via the intrinsic and extrinsic pathways plays a central role in the blood coagulation)<\/p>\n

Unlike the previously best known anticoagulant Warfarin<\/b>, Eliquis is far much better because it significantly reduces:<\/h3>\n
    \n
  • Risk of stroke or systemic embolism by 21%<\/li>\n
  • Risk of major bleeding by 31%<\/li>\n
  • Mortality by 11%<\/li>\n<\/ul>\n

    3.) Pfizer predicted first-year sales of $350 million<\/h2>\n

    after the FDA approved the drug. However, Eliquis sales for 2013 could not even reach $129 million marks. While, global sales of PRADAXA?<\/sup> were $875 million and $582 million for XARELTO?<\/sup>. Eliquis and Pradaxa are both better than warfarin in preventing stroke. Only Eliquis, however, reduced major bleeding over warfarin and improved mortality. According to the Bristol-Myers Squibb Reports First Quarter 2014 Financial Results, Global revenues for Eliquis were $106 million.Analysts are forecasting a $9 billion market for new blood thinners and a drug that fit Apixabans efficacy and safety profile could snatch half of that. Leerink Swann’s Seamus Fernandez estimated peak Eliquis sales at $4.2 billion in 2017<\/b><\/p>\n

    If you?re new to Eliquis you likely have some questions about the drug. So let?s dive into the most important information about this drug.<\/p>\n

    4.) General Instruction for Use<\/b><\/h2>\n

    The primary use of this medicine is for stroke and clot prevention in people with atrial fibrillation.<\/b><\/p>\n

    The usual dose is 5 mg twice daily (once in the morning and once in the evening, about 12 hours apart).<\/p>\n

    Unlabeled<\/b> Uses:<\/h3>\n
      \n
    • To reduce the risk of recurrent DVT and\/or PE (in patients completing 6-12 months of standard anticoagulation for venous thromboembolism).<\/li>\n
    • Postoperative DVT prophylaxis for arthroplasty of the knee.<\/li>\n
    • Postoperative DVT prophylaxis for total hip replacement.<\/li>\n<\/ul>\n

      Reduced Dosages:<\/h3>\n

      A reduced dose of 2.5 mg orally twice daily is recommended for patients with 2 or more of the following:<\/p>\n

        \n
      • Age of 80 years or greater<\/li>\n
      • Body weight of 60 kg or less<\/li>\n
      • Serum creatinine of 1.5 mg\/dL or greater<\/li>\n<\/ul>\n

        Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.<\/p>\n

        What to do concerning Missed Doses?<\/b><\/h3>\n

        If a dose is missed, administer the missed dose as soon as possible on the same day and resume twice daily administration. Doses should not be doubled.<\/p>\n

        Modifying Doses:<\/b><\/p>\n

        For Renal impaired patients<\/span><\/h4>\n
          \n
        • Mild-Moderateimpairment: No dosage adjustment required<\/li>\n
        • Serum creatinine ?1.5 mg\/dL: Decrease dose to 2.5 mg BID if you are of age ?80 years or weight ?60 kg.<\/li>\n
        • ESRD maintained on hemodialysis: 5 mg BID;decrease dose to 2.5 mg BID if you are of age ?80 years or weight ?60 kg.<\/li>\n<\/ul>\n

          For Hepatic impaired patient<\/span><\/h4>\n
            \n
          • Mild: Not dosage adjustment required<\/li>\n
          • Moderate: No dosing recommendations are available, because these patients may have intrinsic coagulation abnormalities.<\/li>\n
          • Severe: Not recommended<\/li>\n<\/ul>\n

            Administration:<\/b><\/h2>\n
              \n
            • May take with or without food<\/li>\n
            • Missed dose: If not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice daily administration should be resumed; do not double the dose to make up for a missed dose<\/li>\n
            • If unable to swallow whole tablets, the tablets may be crushed and suspended in 60 mL D5W and immediately delivered via NG tube<\/li>\n<\/ul>\n

              NOTE:<\/b>No data are available in respect of the safety and efficacy of Eliquis in children. Use of Eliquis is not recommended in children.<\/p>\n

              \"\"<\/p>\n

              5.) Can you Overdose on Eliquis?<\/b><\/h2>\n

              The amount of this medication needed to result in an overdose\u00a0<\/b>greatly depends on the individual characteristics of the user.<\/p>\n

              In controlled clinical trials, orally administered Apixaban in healthy subjects at doses up to 50mg daily for 3 to 7 days (25mg twice daily for 7 days or 50mg once daily for 3 days) had no clinically relevant adverse effects.<\/p>\n

              However, <\/span>Overdose of Eliquis will greatly increase the risk of severe bleeding in patient.<\/p>\n

              Can an overdose of this drug result in death??<\/b><\/h3>\n

              Yes, this medication can cause bleeding which can be serious and rarely may lead to death.<\/p>\n

              In the event of an expected overdose, you or your loved ones should take immediate action and seek medical help.<\/h3>\n

              Any?noticeable negative side effect is cause for a medical consultation. These and other symptoms might be signs of an allergy, incompatible drug interactions, or other complications and should be addressed as soon as possible.<\/p>\n

              Management of Overdoses will vary<\/b>.<\/h3>\n

              If the overdose was recent, a healthcare provider may give certain medicines or place a tube into the stomach to pump the stomach.<\/p>\n

              In healthy subjects, administration of activated charcoal 2 and 6 hours after ingestion of a 20-mg dose of Apixaban reduced mean drug AUC by 50% and 27%, respectively.<\/p>\n

              Thus, administration of activated charcoal may be useful in the management of Apixaban overdose or accidental ingestion.<\/p>\n

              Once Apixaban has been absorbed into the body, there is no treatment that can remove it quickly and so specific antidotes are known. However, not all hope is lost. An investigational new drug is entering the market known as Andexanet alfa<\/b>, which is claimed to be a potential antidote for Factor Xa inhibitors.<\/p>\n

              But for now, the possibility of multiple drugs is considered to <\/span>manage overdosage.<\/p>\n

              6.) Eliquis and Severe Bleeding<\/b><\/h2>\n

              Call your doctor or get medical help right away if you have any of these signs or symptoms of bleeding when taking Eliquis:<\/b><\/p>\n

                \n
              • Unexpected bleeding or bleeding that lasts a long time, such as unusual bleeding from the gums, nosebleeds that happen often, menstrual bleeding or vaginal bleeding that is heavier than normal.<\/li>\n
              • Bleeding that is severe or you cannot control<\/li>\n
              • Red, Pink, or Brown urine<\/li>\n
              • Red or Black stools (looks like tar)<\/li>\n
              • Coughing up blood or blood clots<\/li>\n
              • Vomit blood or your vomit looks like coffee grounds<\/li>\n
              • Unexpected pain, swelling, or joint pain<\/li>\n
              • Headaches, feeling dizzy or muscle weakness<\/li>\n<\/ul>\n

                In the event of hemorrhagic complications, treatment must be discontinued and the source of bleeding investigated. The initiation of appropriate treatment, e.g., surgical hemostasis or the transfusion of fresh frozen plasma should be considered.<\/p>\n

                NOTE: <\/b>If life-threatening bleeding cannot be controlled by the above measures, administration of recombinant Factor VIIa may be considered. However, there is currently no experience with the use of recombinant Factor VIIa in individuals receiving Apixaban. Re-dosing of recombinant Factor VIIa could be considered and titrated depending on improvement of bleeding. Depending on local availability, a consultation of a coagulation expert should be considered in case of major bleedings.<\/p>\n

                7.) Associated Side effects and Risks<\/h2>\n

                a.) Adverse drug reactions (ADRs)<\/b> shown to occur with more than 50mg\/day dosage at rate higher than seen with placebo:<\/p>\n

                Very common Side effects (>10% incidence)?<\/b><\/h3>\n